268 related articles for article (PubMed ID: 34577150)
1. The Development of Ru(II)-Based Photoactivated Chemotherapy Agents.
Chen Y; Bai L; Zhang P; Zhao H; Zhou Q
Molecules; 2021 Sep; 26(18):. PubMed ID: 34577150
[TBL] [Abstract][Full Text] [Related]
2. A Ru-anthraquinone dyad with triple functions of PACT, photoredox catalysis and PDT upon red light irradiation.
Zhang C; Guo X; Da X; Wang Z; Wang X; Zhou Q
Dalton Trans; 2021 Aug; 50(31):10845-10852. PubMed ID: 34296720
[TBL] [Abstract][Full Text] [Related]
3. Kinetically labile ruthenium(II) complexes of terpyridines and saccharin: effect of substituents on photoactivity, solvation kinetics, and photocytotoxicity.
Kumar P; Singh P; Saren S; Pakira S; Sivakumar S; Patra AK
Dalton Trans; 2021 Jun; 50(23):8196-8217. PubMed ID: 34031678
[TBL] [Abstract][Full Text] [Related]
4. Development of Ruthenium Nanophotocages with Red or Near-Infrared Light-Responsiveness.
Zhang Z; He M; Wang R; Fan J; Peng X; Sun W
Chembiochem; 2023 Dec; 24(24):e202300606. PubMed ID: 37837285
[TBL] [Abstract][Full Text] [Related]
5. Ruthenium-Based Photoactivated Chemotherapy.
Bonnet S
J Am Chem Soc; 2023 Nov; 145(43):23397-23415. PubMed ID: 37846939
[TBL] [Abstract][Full Text] [Related]
6. Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives.
Lee SY; Kim CY; Nam TG
Drug Des Devel Ther; 2020; 14():5375-5392. PubMed ID: 33299303
[TBL] [Abstract][Full Text] [Related]
7. Lightening up Ruthenium Complexes to Fight Cancer?
Mari C; Gasser G
Chimia (Aarau); 2015; 69(4):176-81. PubMed ID: 26668934
[TBL] [Abstract][Full Text] [Related]
8. A nuclear permeable Ru(ii)-based photoactivated chemotherapeutic agent towards a series of cancer cells: in vitro and in vivo studies.
Tian N; Feng Y; Sun W; Lu J; Lu S; Yao Y; Li C; Wang X; Zhou Q
Dalton Trans; 2019 May; 48(19):6492-6500. PubMed ID: 30994660
[TBL] [Abstract][Full Text] [Related]
9. Novel Ru(II) complexes with multiple anticancer photoreactivity: ligand exchange, photoredox catalysis, reactive oxygen generation and endoperoxide formation.
Dao A; Wu H; Wei S; Huang H
Phys Chem Chem Phys; 2023 Jul; 25(29):20001-20008. PubMed ID: 37461395
[TBL] [Abstract][Full Text] [Related]
10. Critical Overview of the Use of Ru(II) Polypyridyl Complexes as Photosensitizers in One-Photon and Two-Photon Photodynamic Therapy.
Heinemann F; Karges J; Gasser G
Acc Chem Res; 2017 Nov; 50(11):2727-2736. PubMed ID: 29058879
[TBL] [Abstract][Full Text] [Related]
11. Fusion of photodynamic therapy and photoactivated chemotherapy: a novel Ru(II) arene complex with dual activities of photobinding and photocleavage toward DNA.
Chen Y; Lei W; Jiang G; Hou Y; Li C; Zhang B; Zhou Q; Wang X
Dalton Trans; 2014 Nov; 43(41):15375-84. PubMed ID: 25188424
[TBL] [Abstract][Full Text] [Related]
12. A mitochondria-targeting dinuclear Ir-Ru complex as a synergistic photoactivated chemotherapy and photodynamic therapy agent against cisplatin-resistant tumour cells.
Zhang C; Guan R; Liao X; Ouyang C; Rees TW; Liu J; Chen Y; Ji L; Chao H
Chem Commun (Camb); 2019 Oct; 55(83):12547-12550. PubMed ID: 31576841
[TBL] [Abstract][Full Text] [Related]
13. Substituent effect and wavelength dependence of the photoinduced Ru-O homolysis in the [Ru(bpy)2(py-SO3)](+)-type complexes.
Zheng Y; Zhou QX; Zhang YY; Li C; Hou YJ; Wang XS
Dalton Trans; 2016 Feb; 45(7):2897-905. PubMed ID: 26752625
[TBL] [Abstract][Full Text] [Related]
14. To cage or to be caged? The cytotoxic species in ruthenium-based photoactivated chemotherapy is not always the metal.
Cuello-Garibo JA; Meijer MS; Bonnet S
Chem Commun (Camb); 2017 Jun; 53(50):6768-6771. PubMed ID: 28597879
[TBL] [Abstract][Full Text] [Related]
15. Strong Influence of Ancillary Ligands Containing Benzothiazole or Benzimidazole Rings on Cytotoxicity and Photoactivation of Ru(II) Arene Complexes.
Lari M; Martínez-Alonso M; Busto N; Manzano BR; Rodríguez AM; Acuña MI; Domínguez F; Albasanz JL; Leal JM; Espino G; García B
Inorg Chem; 2018 Nov; 57(22):14322-14336. PubMed ID: 30379535
[TBL] [Abstract][Full Text] [Related]
16. Photoactivated full-API nanodrug (FAND): harnessing transition metal complexes and MTH1 inhibitor for enhanced DNA damage in cancer cells.
Zhu H; Cui M; Tang Q; Zhao H; Zhang P; Zeng S; Li W; Zhou Q; Zhang J; Chen Y
Biomater Sci; 2024 Jun; 12(12):3154-3162. PubMed ID: 38687170
[TBL] [Abstract][Full Text] [Related]
17. Photoinduced synergistic cytotoxicity towards cancer cells
Han Z; Chen Y; Wang Y; Shi X; Yuan H; Bai Y; Chen Z; Fang H; He W; Guo Z
Dalton Trans; 2020 Oct; 49(40):13954-13957. PubMed ID: 33000850
[TBL] [Abstract][Full Text] [Related]
18. Two novel BODIPY-Ru(ii) arene dyads enabling effective photo-inactivation against cancer cells.
Wang T; Hou Y; Chen Y; Li K; Cheng X; Zhou Q; Wang X
Dalton Trans; 2015 Jul; 44(28):12726-34. PubMed ID: 26087131
[TBL] [Abstract][Full Text] [Related]
19. Photo-induced DNA cleavage and cytotoxicity of a ruthenium(II) arene anticancer complex.
Brabec V; Pracharova J; Stepankova J; Sadler PJ; Kasparkova J
J Inorg Biochem; 2016 Jul; 160():149-55. PubMed ID: 26778426
[TBL] [Abstract][Full Text] [Related]
20. Tuning Polyamidoamine Design To Increase Uptake and Efficacy of Ruthenium Complexes for Photodynamic Therapy.
Mascheroni L; Dozzi MV; Ranucci E; Ferruti P; Francia V; Salvati A; Maggioni D
Inorg Chem; 2019 Nov; 58(21):14586-14599. PubMed ID: 31618015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
